Mark Schneyer
CFO
CFO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Acadia Pharmaceuticals Inc (ACAD) | Chief Financial Officer | $467,283 | $2,353,204 |
| 2021 | Acadia Pharmaceuticals Inc (ACAD) | Chief Financial Officer | $398,183 | $3,182,819 |
Earnings-call appearances
-
Acadia Pharmaceuticals Inc Q1 FY2026 Earnings Call2026-05-06
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q3 FY2025 Earnings Call2025-11-05
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q2 FY2025 Earnings Call2025-08-06
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q4 FY2024 Earnings Call2025-02-26
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q3 FY2024 Earnings Call2024-11-06
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q2 FY2024 Earnings Call2024-08-06
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q1 FY2024 Earnings Call2024-05-08
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q4 FY2023 Earnings Call2024-02-27
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q3 FY2023 Earnings Call2023-11-02
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q2 FY2023 Earnings Call2023-07-18
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q1 FY2023 Earnings Call2023-05-08
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q4 FY2022 Earnings Call2023-02-28
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q2 FY2022 Earnings Call2022-08-08
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q1 FY2022 Earnings Call2022-05-04
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q4 FY2021 Earnings Call2022-02-28
Acadia Pharmaceuticals Inc (ACAD)
-
Acadia Pharmaceuticals Inc Q3 FY2021 Earnings Call2021-11-08
Acadia Pharmaceuticals Inc (ACAD)